About: Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate

An Entity of Type: combination drug, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate (EDBu/OHPH/TCa), sold under the brand name Triormon Depositum, is an injectable combination medication of estradiol dibutyrate (EDBu), an estrogen, hydroxyprogesterone heptanoate (OHPH), a progestogen, and testosterone caproate (TCa), an androgen/anabolic steroid, which was used in the treatment of menopausal symptoms in women. It contained 3 mg EDBu, 30 mg OHPH, and 50 mg TCa in oil solution and was administered by intramuscular injection. The medication was developed by 1957. It is no longer available.

Property Value
dbo:abstract
  • Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate (EDBu/OHPH/TCa), sold under the brand name Triormon Depositum, is an injectable combination medication of estradiol dibutyrate (EDBu), an estrogen, hydroxyprogesterone heptanoate (OHPH), a progestogen, and testosterone caproate (TCa), an androgen/anabolic steroid, which was used in the treatment of menopausal symptoms in women. It contained 3 mg EDBu, 30 mg OHPH, and 50 mg TCa in oil solution and was administered by intramuscular injection. The medication was developed by 1957. It is no longer available. (en)
dbo:alternativeName
  • Triormon Depositum (en)
dbo:wikiPageID
  • 61125384 (xsd:integer)
dbo:wikiPageLength
  • 3914 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1110812922 (xsd:integer)
dbo:wikiPageWikiLink
dbp:class
dbp:component
  • Estradiol dibutyrate (en)
  • Hydroxyprogesterone heptanoate (en)
  • Testosterone cyclohexylpropionate (en)
dbp:drugName
  • EDBu/OHPH/TCa (en)
dbp:routesOfAdministration
dbp:synonyms
  • EDBu/OHPH/TCa (en)
dbp:title
dbp:titlestyle
  • background:#ccccff (en)
dbp:tradename
  • Triormon Depositum (en)
dbp:type
  • combo (en)
dbp:wikiPageUsesTemplate
dcterms:subject
rdf:type
rdfs:comment
  • Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate (EDBu/OHPH/TCa), sold under the brand name Triormon Depositum, is an injectable combination medication of estradiol dibutyrate (EDBu), an estrogen, hydroxyprogesterone heptanoate (OHPH), a progestogen, and testosterone caproate (TCa), an androgen/anabolic steroid, which was used in the treatment of menopausal symptoms in women. It contained 3 mg EDBu, 30 mg OHPH, and 50 mg TCa in oil solution and was administered by intramuscular injection. The medication was developed by 1957. It is no longer available. (en)
rdfs:label
  • Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate (en)
owl:sameAs
prov:wasDerivedFrom
foaf:isPrimaryTopicOf
foaf:name
  • EDBu/OHPH/TCa (en)
is dbo:wikiPageRedirects of
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License